Neurological Biomarkers Market- Size, Share & Forecast .


Posted October 24, 2023 by ChaithanyaVaishnav

Global neurological biomarkers market size is expected at $15.07 Bn by 2027 at a growth rate of 12.3% and growth analysis by The Business Research Company.
 
The Business Research Company’s Neurological Biomarkers Global Market Report 2023 is the most detailed report available on the market, including broad forecast periods and multiple geographies. The report covers the historic period – 2010-2021, and the forecast period – 2023-2032. The Neurological Biomarkers Global Market Report 2023 evaluates neurological biomarkers market size, growth rate, drivers, trends, and major companies.

The report provides a global perspective by covering 60 geographies and focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=12677&type=smp

The global neurological biomarkers market is expected to grow from $8.40 billion in 2022 to $9.46 billion in 2023 at a compound annual growth rate (CAGR) of 12.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and resulted in increased interest rates affecting many markets across the globe. The neurological biomarkers market is expected to reach $15.07 billion in 2027 at a CAGR of 12.3%.

The increasing prevalence of neurological diseases is expected to propel the growth of the neurological biomarker market going forward. Neurological illnesses affect the brain, spinal cord, and all of the body's other nerves. Parkinson's disease is a neurodegenerative disorder affecting the neurological system and the areas of the body that are under the control of the nerves. Neurological biomarkers help provide an early diagnosis of Parkinson's disease using pathological, biochemical, and genetic testing. For instance, in December 2022, according to the Parkinson's Foundation, a US-based non-profit organization, the number of new diagnoses of Parkinson's disease reached 90,000 in 2022, up from 60,000 per year in 2021. Therefore, the increasing prevalence of neurological diseases is driving the growth of the neurological biomarker market.

Get More Information On The Neurological Biomarkers Market Report:

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

The neurological biomarkers market segments in the report are:

1) By Product: Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products

2) By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington's Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy

3) By End-User: Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Other End-Users

The table of contents in TBRC’s neurological biomarkers market report includes:

Executive Summary
Neurological Biomarkers Market Characteristics
Neurological Biomarkers Market Trends And Strategies
Neurological Biomarkers Market - Macro Economic Scenario
Neurological Biomarkers Market Segmentation
.

.

.

Global Neurological Biomarkers Market Competitive Benchmarking
Global Neurological Biomarkers Market Competitive Dashboard
Key Mergers And Acquisitions In The Neurological Biomarkers Market
Neurological Biomarkers Market Future Outlook and Potential Analysis
Appendix
Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293



Email: [email protected]



Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By SamLutherford
Business Address [email protected]
Country United States
Categories Biotech , Health , Medical
Tags neurological biomarkers market size , neurological biomarkers market share , neurological biomarkers market growth
Last Updated October 24, 2023